Literature DB >> 19125256

Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice.

Yutaka Nishio1, Masao Koda, Masayuki Hashimoto, Takahito Kamada, Shuhei Koshizuka, Katsunori Yoshinaga, Shin Onodera, Jun Nishihira, Akihiko Okawa, Masashi Yamazaki.   

Abstract

Macrophage migration inhibitory factor (MIF) is a multipotential protein that acts as a proinflammatory cytokine, a pituitary hormone, and a cell proliferation and migration factor. The objective of this study was to elucidate the role of MIF in spinal cord injury (SCI) using female MIF knockout (KO) mice. Mouse spinal cord compression injury was produced by application of a static load (T8 level, 20 g, 5 min). We analyzed the motor function of the hind limbs and performed histological examinations. Hind-limb function recovered significantly in the KO mice starting from three weeks after injury. Cresyl-violet staining revealed that the number of surviving neurons in the KO mice was significantly larger than that of WT mice six weeks after injury. Immunohistochemical analysis revealed that the number of NeuN/caspase-3-active, double-positive, apoptotic neurons in the KO mice was significantly smaller than that of the WT mice 24 and 72 h after SCI. These results were related to in-vitro studies showing increased resistance of cerebellar granular neurons from MIF-KO animals to glutamate neurotoxicity. These results suggest that MIF existence hinders neuronal survival after SCI. Suppression of MIF may attenuate detrimental secondary molecular responses of the injured spinal cord.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19125256     DOI: 10.1007/s00401-008-0476-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  23 in total

Review 1.  Macrophage migration inhibitory factor as a therapeutic target after traumatic spinal cord injury: a systematic review.

Authors:  Seyed Mohammad Piri; Zahra Ghodsi; Sina Shool; Ali Anjomshoa; Amir Azarhomayoun; Ehsan Jangholi; Hamid Reza Dehghan; Rasha Atlasi; Alexander R Vaccaro; Vafa Rahimi-Movaghar
Journal:  Eur Spine J       Date:  2021-01-24       Impact factor: 3.134

Review 2.  Repertoire of microglial and macrophage responses after spinal cord injury.

Authors:  Samuel David; Antje Kroner
Journal:  Nat Rev Neurosci       Date:  2011-06-15       Impact factor: 34.870

3.  Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain.

Authors:  Amanda Ellis; Julie Wieseler; Jacob Favret; Kirk W Johnson; Kenner C Rice; Steven F Maier; Scott Falci; Linda R Watkins
Journal:  J Pain       Date:  2014-01-09       Impact factor: 5.820

4.  Expression of macrophage migration inhibitory factor in the mouse neocortex and posterior piriform cortices during postnatal development.

Authors:  Wei Zhang; Lingling Li; Jiutao Wang; Lei An; Xinde Hu; Jiongfang Xie; Runchuan Yan; Shulin Chen; Shanting Zhao
Journal:  Cell Mol Neurobiol       Date:  2014-08-14       Impact factor: 5.046

5.  Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke.

Authors:  Ana R Inácio; Karsten Ruscher; Lin Leng; Richard Bucala; Tomas Deierborg
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-10       Impact factor: 6.200

6.  Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice.

Authors:  L Christine Turtzo; Jun Li; Rebecca Persky; Sharon Benashski; Gillian Weston; Richard Bucala; Venugopal Reddy Venna; Louise D McCullough
Journal:  Neurobiol Dis       Date:  2013-01-30       Impact factor: 5.996

7.  Neuroprotective effects of sulforaphane after contusive spinal cord injury.

Authors:  Andrea L Benedict; Andrea Mountney; Andres Hurtado; Kelley E Bryan; Ronald L Schnaar; Albena T Dinkova-Kostova; Paul Talalay
Journal:  J Neurotrauma       Date:  2012-09-20       Impact factor: 5.269

8.  Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory/immune response during the first week after stroke.

Authors:  Ana R Inácio; Richard Bucala; Tomas Deierborg
Journal:  J Neuroinflammation       Date:  2011-06-29       Impact factor: 8.322

9.  Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures.

Authors:  Natalia Malek; Katarzyna Popiolek-Barczyk; Joanna Mika; Barbara Przewlocka; Katarzyna Starowicz
Journal:  Neural Plast       Date:  2015-05-18       Impact factor: 3.599

10.  D-dopachrome tautomerase activates COX2/PGE2 pathway of astrocytes to mediate inflammation following spinal cord injury.

Authors:  Huiyuan Ji; Yuxin Zhang; Chen Chen; Hui Li; Bingqiang He; Ting Yang; Chunshuai Sun; Huifei Hao; Xingyuan Zhang; Yingjie Wang; Yue Zhou; Zhenjie Zhu; Yuming Hu; Aihong Li; Aisong Guo; Yongjun Wang
Journal:  J Neuroinflammation       Date:  2021-06-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.